Biomarker Testing Market Projected To Reach USD 50.76 Billion By 2035, Driven By Personalized Medicine And Oncology Advancements SNS Insider. The global market, valued at USD 32.69 billion in 2025, is ...

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting, ...

According to MarketsandMarkets™, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion ...

According to MarketsandMarkets, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion in 2026 to USD 16.39 ...

The Middle East renal biomarkers market is set for growth due to rising kidney disease linked to diabetes, hypertension, and ...

Opportunities lie in integrating advanced diagnostics and digital solutions, leveraging partnerships, and enhancing supply ...

High-dose biotin can interfere with thyroid lab tests, leading to misleading results even when your thyroid is healthy, says Luke Coutinho.

Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...

NEWARK, Del., Jan. 15, 2026 /PRNewswire/ -- As the global healthcare landscape moves toward a personalized, data-driven future, the demand for high-precision diagnostic tools is reaching an all-time ...

Tacrolimus is a widely used immunosuppressive therapy in transplant recipients, but its narrow therapeutic index necessitates accurate monitoring. Tacrolimus levels can be quantified using ...